Straits Times Index
3,426.47 -3.98 (-0.12%) Nikkei
37,667.41 -202.10 (-0.53%) Hang Seng
17,021.31 +16.34 (+0.10%) FTSE 100
8,285.71 +99.36 (+1.21%) Bitcoin USD
68,924.88 +1,676.27 (+2.49%) CMC Crypto 200
1,396.99 +66.38 (+4.99%)
LifeStance Health Group, Inc. (LFST)
After hours:
| Previous close | 5.54 |
| Open | 5.65 |
| Bid | 5.56 x 300 |
| Ask | 5.59 x 300 |
| Day's range | 5.51 - 5.72 |
| 52-week range | 4.64 - 9.50 |
| Volume | |
| Avg. volume | 1,733,756 |
| Market cap | 2.133B |
| Beta (5Y monthly) | 1.19 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
All You Need to Know About LifeStance Health (LFST) Rating Upgrade to Strong Buy
LifeStance Health (LFST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
- Zacks
Wall Street Analysts See a 57.38% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 57.4% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- Zacks
Down -8.97% in 4 Weeks, Here's Why You Should You Buy the Dip in LifeStance Health (LFST)
The heavy selling pressure might have exhausted for LifeStance Health (LFST) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
